Ibrance
Palbociclib (codenamed PD-0332991, trade name Ibrance) is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Mechanism of action
It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
1 Basic information:
Palbociclib
CAS 571190-30-2
CAS         571190-30-2
Brand: Renyoung
MF         C24H29N7O2
Molecular Weight:
Min order: 10grams
Product Categories:
Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fin e Chemicals.
Usage
A cyclin-dependent kinase (CDK) inhibitor
Standard
Purity:>99%
Appearance
White Crystal  powder
Shelf life
2 years
Storage
Palbociclib  should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
2. COA
Items
Specifications
Results
Appearance
A white or off white crystalline powder
White crystalline powder
Solubility
Freely soluble in chloroform
Conform
Specific rotation(0)[α]D20
+75~+84
+78.6
Loss on drying(%)
≤1.0
0.73
Residue on ignition(%)
≤0.1
0.03
Heavy metals(ppm)
≤20
conform
Metling point()
178-193 centi-degree
186-190centi-degree
Purity(HPLC,%)
≥98.0
99.6%
Related substances(HPLC)
Single impurity: ≤0.5%
Total impurity: ≤1.0%
Conform
3. Usage:
For Breast cancer treatment or as pharmaceutical intermediates.
4. Packaging & Shipping:
Packaging Details:
25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging   aluminium bag outside and double plastic bag inside
Delivery Detail: within 3 days when get the payment
Shipping :
We have  Professional  shipping agent, based on customers ‘ demand for transport
By express :FEDEX,DHL,EMS ,UPS,TNT ect.
By SEA and By AIR

my contact infomation is:
Whatsapp: 008615032102186
Email: bettyapi1989@163.com

Notice: This product is only suitable for laboratory use, or the use of animals. It can not be used directly on the human body

 

Advertisements